J. Bourguignon

发表

Trends in age at diagnosis of Turner syndrome

F. de Zegher, M. Craen, C. Heinrichs, 2005, Archives of Disease in Childhood.

Identification of novel and recurrent glucokinase mutations in Belgian and Luxembourg maturity onset diabetes of the young patients

C. de Beaufort, Raoul Rooman, C. Mathieu, 2006, Clinical genetics.

Treatment of central precocious puberty with an intranasal analogue of GnRH (Buserelin)

J. Bourguignon, M. Craen, J. Bourguignon, 1987, European Journal of Pediatrics.

ADULTHOOD: THE BELGIAN EXPERIENCE

G. Massa, C. Heinrichs, J. Bourguignon, 2021 .

Effects of 17 months treatment using recombinant insulin‐like growth factor‐I in two children with growth hormone insensitivity (Laron) syndrome

C. Heinrichs, J. Bourguignon, P. Bergmann, 1993, Clinical endocrinology.

Health and Psychosocial Status of Patients with Turner Syndrome after Transition to Adulthood: The Belgian Experience

M. Craen, C. Heinrichs, G. Massa, 2004, Hormone Research in Paediatrics.

Growth hormone therapy in Turner's syndrome: one versus two daily injections.

M. Craen, C. Heinrichs, G. Massa, 1994, The Journal of clinical endocrinology and metabolism.

Environmental factors and human puberty

J. Bourguignon, 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Prevalence and demographic features of childhood growth hormone deficiency in Belgium during the period 1986-2001.

F. de Zegher, M. Craen, C. Heinrichs, 2004, European journal of endocrinology.

High-dose growth hormone treatment of short children born small for gestational age.

F. de Zegher, L. Breysem, M. Craen, 1996, The Journal of clinical endocrinology and metabolism.

Factors contributing to the impairment of growth in children with acute lymphoblastic leukemia.

M. Craen, Y. Benoît, J. Bourguignon, 1988, Hormone research.

Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.

M. Craen, C. Heinrichs, G. Massa, 2003, The Journal of clinical endocrinology and metabolism.

Pubertal growth and final height in hypopituitary boys: a minor role of bone age at onset of puberty.

J. Bourguignon, J. Bourguignon, M. D. Du Caju, 1986, The Journal of clinical endocrinology and metabolism.

Neuroendocrine Control of the Onset of Puberty: Secretion of Gonadotrophin‐Releasing Hormone from Rat Hypothalamic Explants

P. Franchimont, J. Bourguignon, A. Gérard, 1991, Acta paediatrica Scandinavica. Supplement.

Growth Hormone (GH) Secretion in Patients with Childhood-Onset GH Deficiency: Retesting after One Year of Therapy and at Final Height

M. Craen, C. Heinrichs, G. Massa, 2003, Hormone Research in Paediatrics.

M. Craen, C. Heinrichs, J. Bourguignon, 1998, The Journal of clinical endocrinology and metabolism.

Final Height in Children with Idiopathic Growth Hormone Deficiency Treated with Recombinant Human Growth Hormone: The Belgian Experience

Raoul Rooman, F. de Zegher, M. Craen, 2001, Hormone Research in Paediatrics.

Longitudinal study of behavioral and affective patterns in girls with central precocious puberty during long‐acting triptorelin therapy

M. Craen, C. Heinrichs, J. Bourguignon, 1997, Acta paediatrica.

Sexual precocity after immigration from developing countries to Belgium: evidence of previous exposure to organochlorine pesticides

J. Bourguignon, C. Charlier, G. Plomteux, 2001 .

Hypopituitarism and idiopathic delayed puberty: a longitudinal study in an attempt to diagnose gonadotropin deficiency before puberty.

P. Franchimont, M. Craen, J. Bourguignon, 1982, The Journal of clinical endocrinology and metabolism.

Growth hormone therapy in pre‐pubertal children with Noonan syndrome: first year growth response and comparison with Turner syndrome

G. Massa, M. Craen, J. Bourguignon, 1997, Acta paediatrica.

Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.

F. de Zegher, M. Craen, C. Heinrichs, 2001, Journal of pediatric endocrinology & metabolism : JPEM.

Variations in pituitary—gonadal suppression during intranasal buserelin and intramuscular depot‐triptorelin therapy for central precocious puberty

M. Craen, C. Heinrichs, J. Bourguignon, 1994, Acta paediatrica.

Evaluation and significance of the degree of pituitary-gonadal inhibition during intranasal administration of buserelin.

M. Craen, J. Bourguignon, M. D. Du Caju, 1987, Acta Endocrinologica.

A valuable improvement of adult height prediction methods in short normal children.

J. Bourguignon, G. Massa, J. Bourguignon, 1997, Hormone research.